The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Longitudinal studies of cognition in schizophrenia: Meta-analysis
Open accessAbstract
Background: A wide range of cognitive deficits have been demonstrated in schizophrenia, but their longitudinal course remains unclear. Aims: To bring together all the available information from longitudinal studies of cognitive performance in people with schizophrenia. Method: We carried out a meta-analysis of 53 studies. Unlike previous reviewers, we included all studies (regardless of the type of medication), analysed each variable separately and compared results with data from controls. Results: Participants with schizophrenia showed a significant improvement in most cognitive tasks. The available data for controls showed, with one exception (the Stroop test), a similar or greater improvement. Performance in semantic verbal fluency remained stable in both individuals with schizophrenia and controls. Conclusions: Participants with schizophrenia displayed improvement in most cognitive tasks, but practice was more likely than cognitive remediation to account for most of the improvements observed. Semantic verbal fluency may be the best candidate cognitive endophenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Snitz, B. E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi048 · Cited by 714
Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 693
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 620
Woodward, N. D., Purdon, S. E., Meltzer, H. Y., & Zald, D. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500516x · Cited by 605
Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538
Goldberg, T. E. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230088014 · Cited by 522
Purdon, S. E. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.249 · Cited by 469
A review of longitudinal studies of cognitive functions in schizophrenia patients
Rund, B. R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033337 · Cited by 451
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.799 · Cited by 397
Hagger, C., Buckley, P., Kenny, J. T., Friedman, L., Ubogy, D., & Meltzer, H. Y. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90043-d · Cited by 393
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
Spohn, H. E., & Strauss, M. E. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.4.367 · Cited by 381
Cognitive deficits as treatment targets in schizophrenia
Gold, J. M. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.008 · Cited by 354
Longitudinal Study of Cognitive Function in First-Episode and Recent-Onset Schizophrenia
Gold, S., Arndt, S., Nopoulos, P., O’Leary, D. S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1342 · Cited by 296
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
Goldberg, T. E., Greenberg, R. D., Griffin, S. J., Gold, J. M., Kleinman, J. E., Pickar, D., Schulz, S. C., & Weinberger, D. R. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.43 · Cited by 289
Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281
Henry, J., & Crawford, J. (2005) · Cognitive Neuropsychiatry · doi:10.1080/13546800344000309 · Cited by 280
Hoff, A. L., Svetina, C., Shields, G., Stewart, J., & DeLisi, L. E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.010 · Cited by 259
DeLisi, L. E., Tew, W., Xie, S.-H., Hoff, A. L., Sakuma, M., Kushner, M., Lee, G., Shedlack, K., Smith, A. M., & Grimson, R. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00376-e · Cited by 257
McGurk, S. R., Mueser, K. T., Harvey, P. D., LaPuglia, R., & Marder, J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1129 · Cited by 243
Letter and category fluency in schizophrenic patients: a meta-analysis
Bokat, C. E., & Goldberg, T. E. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00282-7 · Cited by 234
Stirling, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00014-8 · Cited by 216
Longitudinal study of symptoms and cognitive function in chronic schizophrenia
Hughes, C., Kumari, V., Soni, W., Das, M., Binneman, B., Drozd, S., O'Neil, S., Mathew, V., & Sharma, T. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00393-0 · Cited by 214
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone
Green, M. F., Marder, S. R., Glynn, S. M., McGurk, S. R., Wirshing, W. C., Wirshing, D. A., Liberman, R. P., & Mintz, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01370-7 · Cited by 202
Conducting Meta-Analysis Using SAS
Arthur, Jr., Bennett, W., & Huffcutt, A. I. (2001) · Psychology Press eBooks · doi:10.4324/9781410600028 · Cited by 190
Practitioner’s Guide to Evaluating Change with Neuropsychological Assessment Instruments
(2000) · Critical issues in neuropsychology · doi:10.1007/978-1-4615-4233-9 · Cited by 186
Does cognitive function improve with quetiapine in comparison to haloperidol?
Velligan, D. I., Newcomer, J., Pultz, J., Csernansky, J., Hoff, A. L., Mahurin, R., & Miller, A. L. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00268-7 · Cited by 183
Purdon, S. E., MALLA, A. K., Labelle, A., & Lit, W. (2001) · PubMed · Cited by 177
Hill, S. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00213-5 · Cited by 168
McGrath, J., Scheldt, S., Welham, J., & Clair, A. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00070-4 · Cited by 158
Cuesta, M. J., Peralta, V., & Zarzuela, A. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00112-2 · Cited by 158
Lysaker, P. H., & Bell, M. D. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199411000-00010 · Cited by 145
Stability of cognitive functioning early in the course of schizophrenia.
Nopoulos, P., Flashman, L., Flaum, M., Arndt, S., & Andreasen, N. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90006-x · Cited by 142
Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis
Szöke, A., Schürhoff, F., Mathieu, F., Méary, A., Ionescu, Ș., & Leboyer, M. (2004) · Psychological Medicine · doi:10.1017/s0033291704003460 · Cited by 138
Self-citationHoff, A. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00242-6 · Cited by 133
Harvey, P. D., Lombardi, J., Leibman, M., WHITE, L. E., Parrella, M. J., Powchik, P., & Davidson, M. (1996) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00075-8 · Cited by 130
Sweeney, J., Haas, G., Keilp, J., & Long, M. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90053-r · Cited by 129
Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study
Rossi, A., Mancini, F., Stratta, P., et al. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00371.x · Cited by 120
A Controlled Trial of Cognitive Remediation in Schizophrenia
van der Gaag, M., Kern, R. S., van den Bosch, R. J., & Liberman, R. P. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006919 · Cited by 117
Harvey, P. D., Meltzer, H. Y., Simpson, G. M., Potkin, S. G., Loebel, A. D., SIU, C. O., & Romano, S. J. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.07.009 · Cited by 104
Smith, T. E., Hull, J. W., Huppert, J. D., & Silverstein, S. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00231-6 · Cited by 92
Fields, R. B., Van Kammen, D. P., Peters, J. L., Rosen, J., Van Kammen, W. B., Nugent, A., Stipetic, M., & Linnoila, M. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90024-2 · Cited by 88
McGurk, S. R., Moriarty, P. J., Harvey, P. D., Parrella, M. J., WHITE, L. E., & Davis, K. L. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00097-3 · Cited by 88
Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia
Penadés, R., Boget, T., Catalán, R., Bernardo, M., Gastó, C., & Salamero, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00359-6 · Cited by 83
Albus, M., Hubmann, W., Scherer, J., Dreikorn, B., Hecht, S., Sobizack, N., & Mohr, F. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0391-4 · Cited by 79
Neuroleptic effects on neuropsychological test performance in schizophrenia
Verdoux, H. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00018-4 · Cited by 79
Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia
Sharma, T., Hughes, C., Soni, W., & Kumari, V. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1506-y · Cited by 73
Stability of Cognitive Performance in Older Patients With Schizophrenia: An 8-Week Test-Retest Study
Harvey, P. D., Palmer, B. W., Heaton, R. K., Mohamed, S., Kennedy, J., & Brickman, A. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.110 · Cited by 62
Effects of psychotropic medication on selected cognitive and perceptual measures.
Killian, G. A., Holzman, P. S., Davis, J. M., & Gibbons, R. D. (1984) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.93.1.58 · Cited by 61
Wölwer, W., & Gäebel, W. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00050-x · Cited by 57
11. Neuropsychological deficits in the early course of first episode schizophrenia
Bilder, R. M., Lipschutz-Broch, L., Reiter, G., Stephen, G., Mayerhoff, D., & Lieberman, J. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90071-x · Cited by 57
Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction
Seidman, L. J., Pepple, J. R., Faraone, S. V., Kremen, W. S., Green, A. I., Brown, W. A., & Tsuang, M. T. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90095-u · Cited by 55
The Scottish First Episode Schizophrenia Study V. One-year Follow-up
McCreadie, R. G., Wiles, D. H., Grant, S. M., MOORE, J. W., Crocket, G. T., Mahmood, Z., Livingston, M. G., Watt, J. A. G., Greene, J. G., Kershaw, P. W., et al. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.152.4.470 · Cited by 52
Neuropsychological change in schizophrenia after 6 weeks of clozapine
Purdon, S. E., Labelle, A., & Boulay, L. J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00101-8 · Cited by 51
The effects of clozapine on cognitive functioning in treatment- resistant schizophrenic patients
Fujii, D. E. M., Ahmed, I., Jokumsen, M., & Compton, J. (1997) · Journal of Neuropsychiatry · doi:10.1176/jnp.9.2.240 · Cited by 47
Townsend, L. A., Norman, R. M. G., MALLA, A. K., Rychlo, A. D., & Ahmed, R. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00236-6 · Cited by 46
Effects of Clozapine on Psychiatric Symptoms, Cognition, and Functional Outcome in Schizophrenia
Manschreck, T. C., Redmond, D. A., Candela, S. F., & Maher, B. A. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.4.481 · Cited by 44
Practitioner’s Guide to Evaluating Change with Intellectual Assessment Instruments
(2000) · Critical issues in neuropsychology · doi:10.1007/978-1-4615-4279-7 · Cited by 40
Deutsch, S. I., Schwartz, B. L., Rosse, R. B., Mastropaolo, J. P., Marvel, C. L., & Drapalski, A. L. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200307000-00010 · Cited by 38
Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome
Gråwe, R. W., & Levander, S. E. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.104s408060.x · Cited by 35
Stip, É., Remington, G. J., Dursun, S. M., Reiss, J. P., Rotstein, E., MacEwan, G. W., Chokka, P. R., Jones, B., & Dickson, R. A. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085414.08426.8f · Cited by 31
Wisconsin card sorting test performance over time in schizophrenia
Seidman, L. J., Pepple, J. R., Faraone, S. V., Kremen, W. S., Cassens, G., McCarley, R. W., & Tsuang, M. T. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90081-2 · Cited by 30
Distractibility and recall capability in schizophrenics
Rund, B. R. (1989) · Schizophrenia Research · doi:10.1016/0920-9964(89)90003-0 · Cited by 26
Neuroleptic dose reduction in older psychotic patients
Harris, M. J., Heaton, R. K., Schalz, A., Bailey, A. L., & Patterson, T. L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00083-2 · Cited by 23
Medicare Part D: early findings on enrollment and choices for rural beneficiaries.
McBride, T. D., Terry, T. L., & Mueller, K. J. (2006) · PubMed · Cited by 23
Chua, L., Chong, S. A., Pang, E., Ng, V. P., & Chan, Y. H. (2001) · PubMed · Cited by 12
Longitudinal Wisconsin Card Sorting Performance in Schizophrenia Patients in Rehabilitation
BRYSON, G. J., Greig, T. C., Lysaker, P. H., & Bell, M. D. (2002) · Applied Neuropsychology · doi:10.1207/s15324826an0904_2 · Cited by 12
Stability of performance on neuropsychological tests in patients with schizophrenia
Rosmark, B., Ösby, U., Engelbrektson, K., & Nyman, H. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050103 · Cited by 12
de Beaurepaire, C., de Beaurepaire, R., Cléau, M., & Borenstein, P. (1993) · European Psychiatry · doi:10.1017/s0924933800001383 · Cited by 7
Cited by
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 741
Cognitive Functioning in Prodromal Psychosis: A Meta-analysis
Fusar-Poli, P., Deste, G., Smieskova, R., Barlati, S., Yung, A. R., Howes, O., Stieglitz, R.-D., Vita, A., McGuire, P., & Borgwardt, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1592 · Cited by 691
“In the absence of significant heterogeneity, the use of a fixed-effects model is legitimate and may provide greater statistical power than the random-effects model.(34) For heterogeneous data, we used random-effects models, which are more conservative than fixedeffects models and appear to better address heterogeneity…”
MethodReview: Inequalities in healthcare provision for people with severe mental illness
Lawrence, D., & Kisely, S. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382058 · Cited by 649
Metadata
- Authors
- Szöke, A., Trandafir, A., Dupont, M.-E., Méary, A., Schürhoff, F., & Leboyer, M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2008-04
- Volume
- 192
- Issue
- 4
- Pages
- 248-257
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2165057078
- Cited by
- 331
- References
- 73
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.